WO2024030098 - A TABLET OF TOLVAPTAN AND AT LEAST ONE BINDER PROCESSED WITH SPRAY GRANULATION

National phase entry is expected:
Publication Number WO/2024/030098
Publication Date 08.02.2024
International Application No. PCT/TR2023/050738
International Filing Date 27.07.2023
Title **
[English] A TABLET OF TOLVAPTAN AND AT LEAST ONE BINDER PROCESSED WITH SPRAY GRANULATION
[French] COMPRIMÉ COMPRENANT DU TOLVAPTAN ET AU MOINS UN LIANT TRAITÉ PAR GRANULATION PAR PULVÉRISATION
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
PEHLIVAN AKALIN, Nur
OZDEN, Aydan
KIVANC, Furkan
Priority Data
2022/012261   03.08.2022   TR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1958
EPO Filing, Examination, Granting9151
Japan Filing, Examination, Granting2000
South Korea Filing, Examination, Granting1802
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,651

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to a tablet comprising an intragranular composition comprising tolvaptan and at least one binder, wherein the intragranular composition is obtained by spray granulation with a solution comprising water and binder.[French] La présente invention concerne un comprimé comprenant une composition intragranulaire comprenant du tolvaptan et au moins un liant, la composition intragranulaire étant obtenue par granulation par pulvérisation avec une solution comprenant de l'eau et un liant.